Publications

2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000



1984 1985 1986 1987 1988 1989 1990

Publications scientifiques 2002 [View all on PubMed]

  1. Abdel-Latif MS, Khattab A, Lindenthal C, Kremsner PG, Klinkert MQ. Recognition of variant Rifin antigens by human antibodies induced during natural Plasmodium falciparum infections. Infect Immun. 2002 Dec;70(12):7013-21 [Abstract] [Free Full Article]
  2. Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, Cobelens F, Diallo S, Faucher JF, Garner P, Gikunda S, Kremsner PG, Krishna S, Lell B, Loolpapit M, Matsiegui PB, Missinou MA, Mwanza J, Ntoumi F, Olliaro P, Osimbo P, Rezbach P, Some E, Taylor WRJ. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet. 2002 Apr 20;359(9315):1365-72 [Abstract]
  3. Binder RK, Borrmann S, Adegnika AA, Missinou MA, Kremsner PG, Kun JFJ. Polymorphisms in the parasite genes for pfcrt and pfmdr-1 as molecular markers for chloroquine resistance in Plasmodium falciparum in Lambarene, Gabon. Parasitol Res. 2002 May;88(5):475-6 [Abstract]
  4. Bongartz M, Rezbach P, Borrmann S, Hollingdale MR, Kremsner PG, Luty AJF. Age-dependent enhancement of IFN-gamma responses to Plasmodium falciparum liver stage antigen-1 Tcell epitopes. Parasitol Res. 2002 Dec;88(12):1083-9 [Abstract]
  5. Borrmann S. JMM past and present. J Mol Med 80: 327-328 (2002) Borrmann S, Binder RK, Adegnika AA, Missinou MA, Issifou S, Ramharter M, Wernsdorfer WH, Kremsner PG. Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon – implications for the value of tests in vitro and in vivo. Trans R Soc Trop Med Hyg. 2002 Nov-Dec;96(6):660-3 [Abstract]
  6. Borrmann S, Szlezak N, Binder RK, Missinou MA, Lell B, Kremsner PG. Evidence for the efficacy of artesunate in asymptomatic Plasmodium malariae infections. J Antimicrob Chemother. 2002 Nov;50(5):751-4 [Abstract]
  7. Faucher JF, Binder R, Missinou MA, Matsiegui PB, Gruss H, Neubauer R, Lell B, Que JU, Miller GB, Kremsner PG. Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines. Clin Infect Dis. 2002 Nov 15;35(10):1147-54 [Abstract]
  8. Faucher JF, Ngou-Milama E, Missinou MA, Ngomo R, Kombila M, Kremsner PG. The impact of malaria on common lipid parameters. Parasitol Res. 2002 Dec;88(12):1040-3 [Abstract]
  9. Gravenor MB, Lloyd AL, Kremsner PG, Missinou MA, English M, Marsh K, Kwiatkowski D. A model for estimating total parasite load in falciparum malaria patients. J Theor Biol. 2002 Jul 21;217(2):137-48 [Abstract]
  10. Huber SM, Uhlemann AC, Gamper NL, Duranton C, Kremsner PG, Lang F. Plasmodium falciparum activates endogenous Cl - channels of human erythrocytes by membrane oxidation. EMBO J. 2002 Jan 15;21(1-2):22-30 [Abstract] [Free Full Article]
  11. Kassberger F, Birkenmaier A, Khattab A, Kremsner PG, Klinkert MQ. PCR typing of Plasmodium falciparum in matched peripheral, placental and umbilical cord blood. Parasitol Res. 2002 Dec;88(12):1073-9 [Abstract]
  12. Klabunde J, Uhlemann AC, Tebo AE, Kimmel J, Schwarz RT, Kremsner PG, Kun JFJ. Recognition of Plasmodium falciparum proteins by mannan-binding lectin, a component of the human innate immune system. Parasitol Res. 2002 Feb;88(2):113-7 [Abstract]
  13. Kremsner PG, Krishna S. Antimalarial cocktails – tropical flavours of the month. Lancet. 2002 Dec 21-28;360(9350):1998-9 [Abstract]
  14. Kun JFJ, Missinou MA, Lell B, Sovric M, Knoop H, Bojowald B, Dangelmaier O, Kremsner PG. New emerging Plasmodium falciparum genotypes in children during the transition phase from asymptomatic parasitemia to malaria. Am J Trop Med Hyg. 2002 Jun;66(6):653-8 [Abstract]
  15. Lell B, Kremsner PG. Clindamycin as an antimalarial drug: review of clinical trials. Antimicrob Agents Chemother. 2002 Aug;46(8):2315-20 [Abstract] [Free Full Article]
  16. Mawili-Mboumba DP, Kun JFJ, Lell B, Kremsner PG, Ntoumi F. Pfmdr1 alleles and response to ultralow-dose mefloquine treatment in Gabonese patients.Antimicrob Agents Chemother. 2002 Jan;46(1):166-70. [Abstract] [Free Full Article]
  17. Meyer CG, May J, Luty AJF, Lell B, Kremsner PG. TNF alpha-308 associated with shorter intervals of Plasmodium falciparum reinfections. Tissue Antigens. 2002 Apr;59(4):287-92 [Abstract]
  18. Missinou MA, Borrmann S, Schindler A, Issifou S, Adegnika AA, Matsiegui PB, Binder R, Lell B, Wiesner J, Baranek T, Jomaa H, Kremsner PG. Fosmidomycin for malaria. Lancet. 2002 Dec 14;360(9349):1941-2 [Abstract]
  19. Nealon C, Dzeing A, Müller-Römer U, Planche T, Sinou V, Kombila M, Kremsner PG, Parzy D, Krishna S. Intramuscular bioavailability and clinical efficacy of artesunate in Gabonese children with severe malaria. Antimicrob Agents Chemother. 2002 Dec;46(12):3933-9 [Abstract] [Free Full Article]
  20. Planche T, Dzeing A, Emmerson AC, Onanga M, Kremsner PG, Engel K, Kombila M, Ngou-Milama E, Krishna S. Plasma glutamine and glutamate concentrations in Gabonese children with Plasmodium falciparum infections. QJM. 2002 Feb;95(2):89-97 [Abstract]
  21. Salanti A, Jensen ATR, Zornig HD, Staalsoe T, Joergensen L, Nielsen MA, Khattab A, Arnot DE, Klinkert MQ, Hviid L, Theander TG. A sub-family of common and highly conserved Plasmodium falciparum var genes. Mol Biochem Parasitol. 2002 Jun;122(1):111-5 [Abstract]
  22. Tebo AE, Kremsner PG, Luty AFJ. Fcgamma receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro. Clin Exp Immunol. 2002 Nov;130(2):300-6 [Abstract] [Free Full Article]
  23. Tebo AE, Kremsner PG, Piper KP, Luty AFJ. Low antibody responses to variant surface antigens of Plasmodium falciparum are associated with severe malaria and increased susceptibility to malaria attacks in Gabonese children. Am J Trop Med Hyg. 2002 Dec;67(6):597-603 [Abstract]
  24. Van Den Biggelaer AHJ, Borrmann S, Kremsner PG, Yazdanbakhsh M. Immune responses induced by repeated treatment do not result in protective immunity to Schistosoma haematobium: Interleukin (IL)-5 and IL-10 responses. J Infect Dis. 2002 Nov 15;186(10):1474-82 [Abstract]
  25. Yazdanbakhsh M, Kremsner PG, Van Ree R. Allergy, parasites and the hygiene hypothesis. Science. 2002 Apr 19;296(5567):490-4 [Abstract]